NEWS ALERT Dr. Steven Brem joins the Musella Foundation as Chief Scientific Advisor!
FDA APPROVAL ALERT Modeyso™ (Onc-201) approved for Recurrent H3K27M-mutant Diffuse Midline Glioma
Our next webinar will be Monday Jan 12, 2026 at 7:00 PM Eastern. Click here for details
Officers and Medical Advisory Board


Our privacy / cookie policy has changed.
Click HERE to read it!